Advertisement

Topics

Series B round brings $60mm to Prelude Therapeutics

15:40 EDT 13 Jun 2019 | Elsevier Business Intelligence

Prelude Therapeutics Inc. (developing cancer therapies targeting treatment resistance mechanisms) raised $60mm in its Series ...

Original Article: Series B round brings $60mm to Prelude Therapeutics

NEXT ARTICLE

More From BioPortfolio on "Series B round brings $60mm to Prelude Therapeutics"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...